Microneedle Drug Delivery CRO/CDMO
Hours: 8:30 AM–5:30 PMSales: +86 10 8928 7035Business: bd@casmn.com

MICRONEEDLE DEVELOPMENT CAPABILITY

Microneedle Analytical and Performance Evaluation

Evaluate critical quality attributes connecting formulation, microneedle structure, delivery performance and stability.
01

When This Capability Is Needed

Evaluate critical quality attributes connecting formulation, microneedle structure, delivery performance and stability.

02

What We Evaluate or Develop

The exact work plan is defined from the product category, payload, target dose, development stage and agreed project objectives.

  • Morphology and mechanical testing
  • Insertion, dissolution and release
  • HPLC, stability, IVRT and IVPT where applicable
03

Typical Project Inputs

Non-confidential payload information, target-product requirements, available development data, target market and expected timeline.

04

Typical Deliverables

Deliverables are agreed before work begins and may include findings, prototype materials, development data, process recommendations or transfer documentation.

Discuss This Capability

Send your target product, payload, development stage and cooperation scope to our business development team.

Start a Project